HealthCanal.com CHAPEL HILL, N.C. – Researchers at the UNC Eshelman School of Pharmacy, UNC School of Medicine, and Rensselaer Polytechnic Institute have created a synthetic form of low-molecular-weight heparin , the effects of which can be quickly reversed in ...
Healio Patients with previous heparin -induced thrombocytopenia, or HIT, who were re-exposed to heparin demonstrated a low risk for recurrent HIT, yet the development of strong heparin -independent platelet-activating antibodies increased that risk, according ...
RedOrbit Low-molecular-weight heparin is commonly used in surgeries to prevent dangerous blood clots. But when patients experience the other extreme – uncontrolled bleeding – in response to low-molecular-weight heparin , there is no antidote. Now researchers at ...
ScienceBlog.com (blog) Researchers at Rensselaer Polytechnic Institute and the University of North Carolina at Chapel Hill (UNC) have created a synthetic form of low-molecular-weight heparin that can be reversed in cases of overdose and would be safer for patients with poor ... and more »
1月12日，海普瑞花20.75亿元收购美国肝素原料药巨头SPL公司100%股权的方案通过了公司董事会的审议，这也是海普瑞继续2012年年底以近1000万美元认购加拿大生物制药企业Prometic Life Sciences Inc增发的4814.7万股后，又一次国际收购。根据并购方案，海普瑞本次出资将分成两个部分，形成“股权+债权”的双重收购模式...
